AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-178084575/approval-fluvoxamine-cr-sad.html" title="Facts and information about Approval: fluvoxamine CR for SAD and OCD.(From the FDA)">Approval: fluvoxamine CR for SAD and OCD.(From the FDA)</a>
Close
Set up an RSS feed that alerts you when new articles from The Brown University Geriatric Psychopharmacology Update are available.
Frequently asked questions about RSS feeds
Approval: fluvoxamine CR for SAD and OCD.(From the FDA)
Fluvoxamine (Luvox) has been approved for treating social anxiety disorder (SAD) and obsessive-compulsive (OCD) in adults. The manufacturer, Solvay Pharmaceuticals, has licensed Jazz Pharmaceuticals …
Related articles from newspapers, magazines, journals, and more
-
- Approval: fluvoxamine CR for SAD and OCD.(From the FDA)
-
Newspaper article from: The Brown University Child and Adolescent Psychopharmacology Update
April 1, 2008
700+ words
-
- Approval: fluvoxamine CR for SAD and OCD.(From the FDA)(Brief article)
-
Magazine article from: Brown University Psychopharmacology Update
June 1, 2008
700+ words
-
- From the FDA.
-
Newspaper article from: The Brown University Child and Adolescent Psychopharmacology Update
June 1, 2008
700+ words
